Cargando…

Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19

Detalles Bibliográficos
Autores principales: Brubaker, Lisa, Mortus, Jared, Cruz, Miguel, Trautner, Barbara, Loor, Michele, Rosengart, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Surgeons. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686709/
https://www.ncbi.nlm.nih.gov/pubmed/33246792
http://dx.doi.org/10.1016/j.jamcollsurg.2020.11.003
_version_ 1783613385199321088
author Brubaker, Lisa
Mortus, Jared
Cruz, Miguel
Trautner, Barbara
Loor, Michele
Rosengart, Todd
author_facet Brubaker, Lisa
Mortus, Jared
Cruz, Miguel
Trautner, Barbara
Loor, Michele
Rosengart, Todd
author_sort Brubaker, Lisa
collection PubMed
description
format Online
Article
Text
id pubmed-7686709
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the American College of Surgeons. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-76867092020-11-25 Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19 Brubaker, Lisa Mortus, Jared Cruz, Miguel Trautner, Barbara Loor, Michele Rosengart, Todd J Am Coll Surg Letter by the American College of Surgeons. Published by Elsevier Inc. 2021-02 2020-11-25 /pmc/articles/PMC7686709/ /pubmed/33246792 http://dx.doi.org/10.1016/j.jamcollsurg.2020.11.003 Text en © 2020 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter
Brubaker, Lisa
Mortus, Jared
Cruz, Miguel
Trautner, Barbara
Loor, Michele
Rosengart, Todd
Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
title Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
title_full Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
title_fullStr Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
title_full_unstemmed Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
title_short Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
title_sort thromboelastography might be more applicable to guide anticoagulant therapy than fibrinolytic therapy in critically ill patients with covid-19
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686709/
https://www.ncbi.nlm.nih.gov/pubmed/33246792
http://dx.doi.org/10.1016/j.jamcollsurg.2020.11.003
work_keys_str_mv AT brubakerlisa thromboelastographymightbemoreapplicabletoguideanticoagulanttherapythanfibrinolytictherapyincriticallyillpatientswithcovid19
AT mortusjared thromboelastographymightbemoreapplicabletoguideanticoagulanttherapythanfibrinolytictherapyincriticallyillpatientswithcovid19
AT cruzmiguel thromboelastographymightbemoreapplicabletoguideanticoagulanttherapythanfibrinolytictherapyincriticallyillpatientswithcovid19
AT trautnerbarbara thromboelastographymightbemoreapplicabletoguideanticoagulanttherapythanfibrinolytictherapyincriticallyillpatientswithcovid19
AT loormichele thromboelastographymightbemoreapplicabletoguideanticoagulanttherapythanfibrinolytictherapyincriticallyillpatientswithcovid19
AT rosengarttodd thromboelastographymightbemoreapplicabletoguideanticoagulanttherapythanfibrinolytictherapyincriticallyillpatientswithcovid19